![]() |
|
![]() |
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
Sponsored by: |
Pfizer |
Information provided by: | Pfizer |
ClinicalTrials.gov Identifier: | NCT00359489 |
Methods study to evaluate use of cardiac ultrasound to assess heart valve abnormality in people.
Condition | Intervention |
Heart Valve Diseases |
Device: cardiac echosonography |
MedlinePlus related topics: | Heart Valve Diseases Ultrasound |
Study Type: | Observational |
Study Design: | Natural History, Longitudinal, Defined Population, Prospective Study |
Official Title: | A Randomized, Open-Label, Methodology Trial To Investigate The Utility Of Echocardiography In Assessment Of Cardiac Valvular Regurgitation In Adult Subjects |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
To obtain contact information for a study center near you, click here. 
![]()   |
Study ID Numbers: | A9001336 |
First Received: | July 31, 2006 |
Last Updated: | September 13, 2007 |
ClinicalTrials.gov Identifier: | NCT00359489 |
Health Authority: | United States: Institutional Review Board |
|
|
![]() |